jdinternationalconsulting.com
Activities - JD Consulting
http://www.jdinternationalconsulting.com/activities
Skip to Main Content. JD consults with all sizes of public and private companies, universities and charities and also CROs. These include retained consultancies, ad hoc consultancies and scientific board memberships. JD is a non executive director of Xenogesis. He is also director of INMED. Drug Design and Drug Discovery. JD works with companies at all stages of drug design, drug discovery and early drug development covering:. All aspects from target selection via CD nomination to early clinical studies.
pharmaphorum.com
Fragile X treatment gets catalyst funding - Pharmaphorum
http://pharmaphorum.com/news/fragile-x-treatment-gets-catalyst-funding
Views & analysis. Charity raises funds for legal fight over HIV drug. Anthill awarded full Veeva certification. The UK’s PPRS and statutory schemes. Sandoz’s Enbrel biosimilar approved in US. Boehringer and Qualcomm collaborate on digital COPD inhaler. Fragile X treatment gets catalyst funding. Twelve exciting new treatments, diagnostics and medical technologies are to receive a total of 18 million ($27.8 million) from a UK government research fund. The funding announcement doesn’t disclose the mec...
howmarshall.wordpress.com
Howard | Howard's Blog
https://howmarshall.wordpress.com/author/howmarshall
SCI Drug Discovery Outsourcing one day conference – 9th June 2010, Belgrave Square, London. June 11, 2010. I attended the Society of Chemical Industry. 8216;s one day conference on the bang-up-to-date topic of Drug Discovery Outsourcing. The organisers had arranged a great programme of speakers from big pharma to virtual R&D companies, service providers and CROs. Dr Alan Moodie, GSK. 8211; Drug Discovery outsourcing – a strategic choice. Dr Luigi La Vecchia, Novartis. Dr Andy Morley, AstraZeneca. Dr Step...
howmarshall.wordpress.com
SCI Drug Discovery Outsourcing one day conference – 9th June 2010, Belgrave Square, London | Howard's Blog
https://howmarshall.wordpress.com/2010/06/11/sci-ddo-2010
SCI Drug Discovery Outsourcing one day conference – 9th June 2010, Belgrave Square, London. SCI Drug Discovery Outsourcing one day conference – 9th June 2010, Belgrave Square, London. June 11, 2010. I attended the Society of Chemical Industry. 8216;s one day conference on the bang-up-to-date topic of Drug Discovery Outsourcing. The organisers had arranged a great programme of speakers from big pharma to virtual R&D companies, service providers and CROs. Dr Alan Moodie, GSK. Dr Luigi La Vecchia, Novartis.
o2h.com
O2h Ventures
http://www.o2h.com/chemistry.aspx
Seeding Life Science and Technology Innovation. Licensing, Medicinal Chemistry and Investment. In-vivo Pharmacology, Toxicology and Pre-clinical. O2h has extensive capability in computational, analytical and synthetic chemistry and allied scale-up capability.
o2h.com
O2h Ventures
http://www.o2h.com/social-enterprise.aspx
Seeding Life Science and Technology Innovation. Are searching for changemakers with ingenious ideas for our social enterprise incubator. We offer support for business model design, finance, HR, and IT, as well as desk space so you can focus on your venture.
o2h.com
O2h Ventures
http://www.o2h.com/collaborative-discovery.aspx
Seeding Life Science and Technology Innovation. Licensing, Medicinal Chemistry and Investment. In-vivo Pharmacology, Toxicology and Pre-clinical. A collaborative approach to drug discovery enables a wider network of skills, energy and resources to come to together in which the success of the program are shared. O2h can bring to bear and invest its extensive pre-clinical capabilities, medicinal chemistry and licensing skills to share or run an end to end program or project to agreed milestones.
o2h.com
O2h Ventures
http://www.o2h.com/community.aspx
Seeding Life Science and Technology Innovation. Licensing, Medicinal Chemistry and Investment. In-vivo Pharmacology, Toxicology and Pre-clinical. In O2h we have made an-going contribution to working in the community in India for more than a decade. o2h endeavours to give time, energy, care and attention to various NGO organisations and in particular the people they serve. In O2h we have an aspiration to develop a hub for social entrepreneurs in Ahmedabad, India.
phoremost.com
Phoremost » Collaborators
http://www.phoremost.com/collaborators
Central to PhoreMost’s mission is the development of a network of co-invested collaborators, who together will be far better placed than single organisations to tackle the complexity of developing future personalised medicines. Libraries and proprietary screening technologies. Its Pharma partners have included Genentech (a member of the Roche Group), MedImmune (the worldwide biologics arm of AstraZeneca), Pfizer, Cubist Janssen. PhoreMost is using Phylogicas Phylomer library as a core element in ...Rsquo...
